TRIAL DETAIL

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor (EORTC-62024)

Drug:	Imatinib
Trial Name:	Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor (EORTC-62024)
NCT#:	NCT00103168
Conditions:	Gastrointestinal Stromal Tumor
Status:	Unknown
Phase:	3	Start Date 12/01/2004	Age of Trial (yrs) 20
Treatment Phase:	Adjuvant
Drug Category:	KIT/PDGFRA inhibitor
Strategy:	Block KIT
Trial Type:	Specifically GIST and only GIST
Other Protocol IDs:	CDR0000410825, EORTC-62024, ISG-62024, FRE-FNCLCC-EORTC-62024, GEIS-EORTC-62024, EUDRACT-2004-001810-16
Sponsor:	EORTC, ISG, FNCLCC, GEIS
Patient Contact:	111 sites recruiting. Lookup NCT00103168. If using clinicaltrials.gov use 'Focused Search' and 'NCT or Study ID' field. If using cancer .gov use 'Advanced Search' and enter NCT # in 'Protocol ID' field
Contact email:
Contact Phone:
Randomized:	Randomized
IV or Oral:	Oral
Trial Notes:	Closed to new patients as of CTOS 11/15/2008. Closure date was 10/20/2008. Clinicaltrials.gov does not reflect closure as of 11/6/2012.

Name	Address	City	State	Zip	Country